Interventional Treatment for Cholangiocarcinoma.
Interventional Treatment for Cholangiocarcinoma.
复制标题
DOI:
10.3389/fonc.2021.671327
复制
发表时间:
2021
影响因子:
4.7
通讯作者:
Guo JH
中科院分区:
文献类型:
--
作者:
Li H;Chen L;Zhu GY;Yao X;Dong R;Guo JH
Cholangiocarcinoma (CCA) is the second most common type of primary liver malignancy. The latest classification includes intrahepatic cholangiocarcinoma and extrahepatic cholangiocarcinoma, with the latter one further categorized into perihilar and distal cholangiocarcinoma. Although surgical resection is the preferred treatment for CCA, less than half of the patients are actually eligible for radical surgical resection. Interventional treatment, such as intra-arterial therapies, ablation, and brachytherapy (iodine-125 seed implantation), has become an acceptable palliative treatment for patients with unresectable CCA. For these patients, interventional treatment is helpful for locoregional control, symptom relief, and improving quality of life. Herein, in a timely and topical manner, we will review these advances and highlight future directions of research in this article.
登录
查看更多内容
影响因子:
--
作者:
Figueroa-Barojas P;Bakhru MR;Habib NA;Ellen K;Millman J;Jamal-Kabani A;Gaidhane M;Kahaleh M
通讯作者:
Kahaleh M
DOI:
10.1016/s1470-2045(20)30157-1
发表时间:
2020-06
期刊:
The Lancet. Oncology
影响因子:
--
作者:
Abou-Alfa GK;Macarulla T;Javle MM;Kelley RK;Lubner SJ;Adeva J;Cleary JM;Catenacci DV;Borad MJ;Bridgewater J;Harris WP;Murphy AG;Oh DY;Whisenant J;Lowery MA;Goyal L;Shroff RT;El-Khoueiry AB;Fan B;Wu B;Chamberlain CX;Jiang L;Gliser C;Pandya SS;Valle JW;Zhu AX
通讯作者:
Zhu AX
影响因子:
2.9
作者:
Carrafiello, Gianpaolo;Lagana, Domenico;Fugazzola, Carlo
通讯作者:
Fugazzola, Carlo
影响因子:
2.5
作者:
Boehm, Lucas M.;Jayakrishnan, Thejus T.;Gamblin, T. Clark
通讯作者:
Gamblin, T. Clark
影响因子:
1.6
作者:
Cui P;Pang Q;Wang Y;Qian Z;Hu X;Wang W;Li Z;Zhou L;Man Z;Yang S;Jin H;Liu H
通讯作者:
Liu H